The aim of our study was to evaluate the association between N-terminal fragment B-type natriuretic peptide (NT-pro-BNP) values and disease severity during the late phase of the pandemic, discovering a possible cut-off value to stratify the disease progression in COVID-19 patients. This evidence concerns the gene NPPB and COVID-19.